Insider buying last 90 days
No open-market insider purchases were filed for DOC in the last 90 days.
From Form 4 filings, dated to when each was filed.
Every DOC insider filing, plotted on the chart in Gekko.Open DOC in Gekko
Healthpeak Properties (DOC) Stock Analysis & Forecast
Sep 28 close
$20.10−0.21 (−1.0%)
Gekko Brief
AI summaryHealthpeak Properties (DOC) closes at $20.10, down 1% on the day, with its price sitting between the 50-day average of $21.12 and the 200-day average of $18.82, a mixed trend. Over the past month the stock is down 5.3% and over three months down 8.1%, though it remains up 21.2% over six months and 8.4% over the year, trading within a 52-week range of $15.70 to $22.95. The GekkoIndex reads 65.2, placing the name in the Accumulation zone, while price stands 23.6% below the Gekko Fair Value of $26.32.
Healthpeak reports next on 22 October 2026, 23 days away, falling inside a typical 20-trading-day holding window; the prior quarter posted actual EPS of $0.28 against a $0.05 estimate, with a 19.7% reaction. One billionaire holder and one trailblazer holder are noted, though no insider, Congress or unusual options activity appears in the recent windows. Seasonally, the next 20 trading days have averaged -0.9% over five years, rising in three of them. Coverage spans 13 firms, three at buy and ten at hold, with a consensus target of $22.95, implying a 14.2% upside from current levels.
Written by AI and checked automatically against the figures on this page. Generated Sep 29, 2026 from the data above.
Healthpeak Properties price vs fair value
Close $20.10200-day averageGekko Fair Value $26.32
Healthpeak Properties quick facts
- Market cap
- $13.86B
- P/E ratio
- 57.9
- Forward P/E
- 169.5
- EPS, TTM
- $0.35
- Revenue, TTM
- $2.95B
- Profit margin
- 8.3%
- Dividend yield
- 5.96%
- Beta
- 0.99
- Volume
- 5.44M avg 5.16M
- 1-year return
- +8.4%
- Typical daily move
- ±1.8%
- Typical 20-day move
- ±4.8%
- 50-day average
- $21.12
- 200-day average
- $18.82
- Next earnings
- Oct 22
- Shares outstanding
- 689.5M
Healthpeak Properties swing-trade checklist
Healthpeak Properties scores 2 supportive, 2 mixed and 1 headwind across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
2 supportive2 mixed1 headwind
- Trendmixed
Averages disagree
Close $20.10 sits between the 50-day ($21.12) and 200-day ($18.82) averages, or the averages disagree.
See the chart - GekkoIndexsupportive
65.2, Accumulation
Reading 65.2 is in the Accumulation zone.
See the GekkoIndex - Fair valuesupportive
23.6% below
Price is 23.6% below Gekko Fair Value (more than 5% below).
See fair value - Smart moneyno data
No data
No insider, Congress or unusual options activity in the window.
See smart money - Earnings riskheadwind
Reports in 23 days
Reports on Oct 22, 2026, 23 days away — inside a typical 20-trading-day hold.
See earnings - Seasonalitymixed
−0.9% on average
From this point in the calendar, the next 20 trading days averaged −0.9% over 5 years, rising in 3 of them.
See seasonality
A description of current data, not a recommendation. How this page works
Healthpeak Properties stock chart and price history
Healthpeak Properties closed at $20.10 on Sep 28, 2026, +8.4% over the past year, inside a 52-week range of $15.70 to $22.95.
Close50-day average200-day averageVolume
Use the left and right arrow keys to read daily values.
Performance Breakdown
- 1 month
- −5.3%
- 3 months
- −8.1%
- 6 months
- +21.2%
- 1 year
- +8.4%
The full DOC chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open DOC in Gekko
Follow Healthpeak Properties through every session
Put DOC on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Track DOC in GekkoFree for 7 days. No credit card required.
About Healthpeak Properties
Healthpeak Properties works as a real estate investment trust, focusing its efforts on properties tied to medical research and healthcare delivery. Rather than spreading across many property types, it concentrates on real estate that supports the science and treatment side of health, acquiring, managing, and developing buildings suited to those specialized uses. This focus on medical and research-oriented facilities is central to how the company is recognized.
As a REIT, Healthpeak generates income primarily through owning and operating these specialized properties, drawing on rental and related revenue from tenants engaged in healthcare and medical research activities. Its portfolio approach centers on holding higher-quality assets within this niche rather than diversifying into unrelated real estate categories.
Healthpeak Properties is included among the constituents of the S&P 500 index. Its shares trade under the ticker DOC.
- Sector
- Finance
- Website
- healthpeak.com
Healthpeak Properties GekkoIndex: the smart money zone
Healthpeak Properties’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 65.2, in the Accumulation zone, up 4.5 points over five sessions.
65.2Accumulation
Up 4.5 points over five sessions.
Reading for Sep 28, 2026
What followed past readings in each zone
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 16 | +0.4% | +3.3% | ||
| Accumulation (current zone) | 221 | +0.5% | +1.1% | ||
| Neutral | 361 | 0.0% | 0.0% | ||
| Distribution | 24 | −0.3% | +2.8% | ||
| Selling | 3 | Too few readings yet | |||
Average DOC share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Accumulation readings averaged +2.3% over 20 days. Past behaviour doesn’t guarantee future results.
Accumulation zone: Institutional interest building. About the five zones →
See every daily GekkoIndex reading plotted over the DOC price, zone by zone.Track DOC in Gekko
Is Healthpeak Properties stock overvalued? Gekko Fair Value
Healthpeak Properties trades 23.6% below Gekko Fair Value of $26.32, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Healthpeak Properties shares are worth, recalculated every trading day.
$26.32
Gekko Fair Value, Sep 26, 2026
23.6% Undervalued
Gekko Fair Value on every chart, with the gap to price updating daily.Open DOC in Gekko
Healthpeak Properties insider and Congress trading
No open-market insider purchases were filed for Healthpeak Properties, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
Congress trades last 90 days
No trades in DOC were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Congress disclosures for DOC, plotted on the chart in Gekko.Open DOC in Gekko
Buybacks
Healthpeak Properties has been buying back its own shares.
- Latest authorization
- $500.0M, Aug 4, 2026
- Bought back, quarter ended Jun 30, 2026
- $100.2M
- As a share of market cap
- 0.72%
- Trailing four quarters
- $101.7M
From company filings.
Hedge funds and billionaires quarter ended Jun 30
2of the funds Gekko tracks hold DOC.
0added1opened1trimmed0sold out
Which funds are on each side, name by name.Unlock in Gekko
Healthpeak Properties earnings: next date and track record
Healthpeak Properties reports on Oct 22, 2026 (23 days away), and beat the EPS estimate in 4 of its last 8 reports.
Next earnings report
Oct 22, 2026
23 days away
- EPS estimate
- $0.05
- Revenue estimate
- $748.4M
4 of 8reports beat the EPS estimate
±6.2%average move across the report
3 of 8reports followed by a gain
Share-price move across each report
Last earnings call, May 5, 2026 AI summary
- What they said
- Healthpeak reported a constructive first quarter with strong execution across outpatient medical and life science businesses, completion of the Janus Living IPO, a Gateway life science acquisition in South San Francisco, and a joint venture recap with Blackstone that raised $170 million. Management highlighted leasing momentum—nearly 1.1 million square feet executed in the quarter for outpatient medical with 5.4% cash re-leasing spreads and 91% occupancy—and positive life science pipeline activity with expectations for net absorption and a targeted 100-basis-point increase in lab occupancy year-over-year by year-end. The Janus Living IPO is expected to be accretive over time (~$0.04 per share run-rate when proceeds are deployed and stabilized) and helped catalyze capital recycling: $1 billion of acquisitions and recaps/sales planned for the year, with about $1 billion of activity essentially complete. Management raised full-year FFO outlook by $0.01 and reiterated disciplined capital allocation, buybacks in April, and selective opportunistic life science acquisition appetite. Headwinds noted include increased interest expense (refinancing of $650 million senior notes), modest G&A and interest expense increases, and ongoing market-level vacancy and supply-demand dynamics in certain submarkets (notably Boston). Overall tone was confident and measured, stressing platform strength, institutional validation (Blackstone JV), and concentration strategy in core markets.
- Guidance
- Raised full-year outlook by $0.01 (FFO guidance increase); Janus Living expected to be accretive roughly $0.04 per share on a run-rate basis once invested and stabilized, with potential incremental earnings (~$0.03) in 2027; life science total occupancy targeted to increase ~100 basis points year-over-year by year-end; same-store NOI guidance flat this quarter (senior housing same-store updated due to IPO); interest expense expected ~$20M higher and G&A ~$5M higher for the year; midpoint run-rate FFO ~ $0.43 per share (+/- $0.01 each quarter).
- Risks flagged
- Refinancing risk (approximately $650M senior notes maturing in June, representing a second-half headwind); ongoing macro and sector uncertainty impacting leasing and tenant behavior; potential known vacates (~50k sq ft midyear) and general vacancy drag in lab portfolio; supply-demand imbalance in certain markets (e.g., Boston) and the long recovery cycle for life science real estate; forward-looking statements are subject to SEC-filed risk factors.
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| May 5, 2026 | $0.28 est $0.05 | $738.8M est $694.6M | +19.7% |
| Feb 2, 2026 | $0.47 est $0.45 | $704.8M est $691.6M | −4.6% |
| Oct 23, 2025 | $0.46 est $0.45 | $705.9M est $685.1M | +0.8% |
| Jul 24, 2025 | $0.46 est $0.46 | $694.3M est $701.7M | −7.6% |
| Apr 24, 2025 | $0.46 est $0.46 | $702.9M est $689.2M | −5.3% |
| Feb 3, 2025 | $0.05 est $0.05 | $698.0M est $698.3M | −2.9% |
| Oct 24, 2024 | $0.05 est $0.05 | $700.4M est $686.1M | −3.6% |
| Jul 25, 2024 | $0.21 est $0.09 | $695.5M est $681.6M | +5.5% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Healthpeak Properties stock forecast and analyst price targets
Analysts’ average 12-month price target for Healthpeak Properties is $22.95, +14.2% from the last close, from 13 firms rating the stock in the last 90 days.
$22.95consensus 12-month target, +14.2% from the last close
Now $20.10Avg $22.95
Low $21High $25
Each firm’s latest rating in the last 90 days: 13 firms.
Latest analyst actions
| Date | Firm | Target | vs price |
|---|---|---|---|
| Sep 21 | Evercore ISI | $22 | +9.5% |
| Sep 15 | Jefferies | $21 | +4.5% |
| Sep 1 | Wells Fargo | $22 | +9.5% |
| Aug 31 | Barclays | $24 | +19.4% |
| Aug 24 | Bank of America Securities | $25 | +24.4% |
+1.1%average 20-day move after past Accumulation readings
−0.9%average move over the next 20 trading days in the last 5 years
±1.8%typical daily move, from the 14-day average range
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Healthpeak Properties seasonality: the next 20 trading days
Over the next 20 trading days from Sep 29, Healthpeak Properties averaged −0.9% across the last 5 years, rising in 3 of them.
Next 20 trading days, by year
Average move and hit rate
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | −1.4% | 2 of 5 |
| Next 10 trading days | −2.9% | 1 of 5 |
| Next 15 trading days | −1.8% | 2 of 5 |
| Next 20 trading days | −0.9% | 3 of 5 |
| Next 30 trading days | −1.4% | 2 of 5 |
For scale, DOC’s typical 20-trading-day move in either direction is about 4.8%.
Healthpeak Properties market cap and key statistics
Healthpeak Properties’s market cap is $13.86B, with a P/E ratio of 57.9 and revenue of $2.95B over the last twelve months.
Valuation
- Market cap
- $13.86B
- P/E ratio
- 57.9
- Forward P/E
- 169.5
- EPS, TTM
- $0.35
- Gekko Fair Value
- $26.32
Trading
- Volume
- 5.44M
- Avg volume, 20 days
- 5.16M
- 52-week high
- $22.95
- 52-week low
- $15.70
- Shares outstanding
- 689.5M
Financials
- Revenue, TTM
- $2.95B
- Profit margin
- 8.3%
- Return on equity
- 3%
- Quarterly earnings growth, YoY
- +68.2%
Risk and income
- Beta
- 0.99
- Typical daily move
- ±1.8%
- Typical 20-day move
- ±4.8%
- Dividend yield
- 5.96%
Healthpeak Properties stock FAQ
What is Healthpeak Properties’s market cap?
Healthpeak Properties’s market cap is $13.86B at the Sep 28, 2026 close of $20.10, with 689.5M shares outstanding. The shares trade on a P/E ratio of 57.9.
What is the Healthpeak Properties stock forecast?
The consensus analyst 12-month price target for Healthpeak Properties is $22.95, +14.2% from the last close. Of the 13 firms that rated the stock in the last 90 days, 3 rate it a buy, 10 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
Is Healthpeak Properties stock overvalued or undervalued?
On Gekko’s estimate Healthpeak Properties is undervalued: the Sep 28, 2026 close of $20.10 is 23.6% below Gekko Fair Value of $26.32. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
When does Healthpeak Properties report earnings next?
Healthpeak Properties is expected to report on Oct 22, 2026 (23 days away). Analysts expect earnings of $0.05 per share on revenue of $748.4M. Healthpeak Properties beat the earnings estimate in 4 of its last 8 reports, moving 6.2% on average across the report.
What is Healthpeak Properties’s 52-week high and low?
Healthpeak Properties’s 52-week high is $22.95 and its 52-week low is $15.70; it closed at $20.10 on Sep 28, 2026, +8.4% over the past year. Over the last five years the shares peaked at $36.85 on Jan 5, 2022.
Is Healthpeak Properties stock a buy right now?
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 2 of the 5 items with data read as supportive (gekkoindex and fair value), 2 as mixed (trend and seasonality) and 1 as a headwind (earnings risk). The checklist is a description of current data, not a recommendation.
How this page works
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
See Healthpeak Properties the way Gekko members do
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,380 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.